<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2022 17_9-10_185</article-id>
<article-id pub-id-type="doi">10.15836/ccar2022.185</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Arrhythmology and electrostimulation</subject></subj-group>
</article-categories>
<title-group>
<article-title>&#x201C;Zero-Fluoro&#x201D; Approach for the repeat pulmonary vein isolation procedures after initial cryoballoon ablation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5425-5840</contrib-id><name><surname>Velagi&#x0107;</surname><given-names>Vedran</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5425-5840</contrib-id><name><surname>Prepolec</surname><given-names>Ivan</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6587-2315</contrib-id><name><surname>Pa&#x0161;ara</surname><given-names>Vedran</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0504-5238</contrib-id><name><surname>Pezo-Nikoli&#x0107;</surname><given-names>Borka</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1477-2581</contrib-id><name><surname>Puljevi&#x0107;</surname><given-names>Mislav</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3603-2242</contrib-id><name><surname>Puljevi&#x0107;</surname><given-names>Davor</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9101-1570</contrib-id><name><surname>Mili&#x010D;i&#x0107;</surname><given-names>Davor</given-names></name></contrib>
<aff id="aff1"><institution content-type="dept">University of Zagreb School of Medicine</institution>, <institution>University Hospital Centre Zagreb</institution>, <addr-line>Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Vedran Velagi&#x0107;, Klini&#x010D;ki bolni&#x010D;ki centar Zagreb, Ki&#x0161;pati&#x0107;eva 12, HR-10000 Zagreb, Croatia. / Phone: +385-91-7929-284 / E-mail: <email xlink:href="vvelagic@gmail.com">vvelagic@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>11</month><year>2022</year></pub-date>
<volume>17</volume>
<issue>9-10</issue>
<fpage>185</fpage>
<lpage>185</lpage>
<history>
<date date-type="received"><day>31</day><month>10</month><year>2022</year></date>
<date date-type="accepted"><day>10</day><month>11</month><year>2022</year></date>
</history>
<permissions>
<copyright-year>2022</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>atrial fibrillation</kwd><kwd>ablation</kwd><kwd>zero-fluoro approach</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: The so called &#x201E;zero fluoro&#x201D; or &#x201E;apron less&#x201D; approach is getting more popular in the electrophysiology labs (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). The main concern of this strategy is its safety. We aimed to demonstrate the feasibility of zero-fluoro approach for the repeat atrial fibrillation (AF) procedures after initial cryoballoon ablation (CB).</p>
<p><bold>Patients and Methods</bold>: We have performed a retrospective study on patients that have undergone repeat pulmonary vein isolation (PVI) procedures in our institution since we started the zero-fluoro program in 2020. All patients received CB ablation for the initial procedure. Procedures were performed under conscious sedation with the help of intracardiac echo (ICE) and 3D mapping system, without the use of fluoroscopy. Right-sided femoral vein was used for the two introducers. A single transseptal puncture was performed guided by ICE. Steerable sheath was used and high-density voltage map of left atrium (LA) was created to evaluate the pulmonary vein (PV) reconnections. Contact-sensing radiofrequency ablation (RF) ablation catheters were used to reisolate the reconnected veins and in the case of no reconnections, posterior wall isolation was performed.</p>
<p><bold>Results</bold>: We have analyzed in total 38 patients (74% male, 59.3&#x00B1;0.3 years old), 53% of which suffered from paroxysmal AF. The mean left ventricular ejection fraction was 61.6&#x00B1;7.0% and mean LA diameter was 42.0&#x00B1;5.2 mm. In two (5.2%) patients RF energy was required to cross the intraatrial septum. In one patient (2.7%) conversion to fluoroscopy was required because of demanding transseptal puncture. The mean procedure time was 98.1.3&#x00B1;26.4 min and the mean RF time was 821 sec&#x00B1;420 sec. The mean of 1.25&#x00B1;0.893 veins were reconnected per patient and 10 patients (26.3%) did not have PV reconnections. In all patients successful PV/PW isolation was performed confirmed by entry and exit block. No periprocedural complications were observed.</p>
<p><bold>Conclusion</bold>: In our cohort of patients, zero-fluoro approach for repeat PVI procedures ablation proved to be feasible and safe. Conversion to fluoroscopy was needed infrequently for more difficult transseptal procedures.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>KD</given-names></name><name><surname>Marine</surname><given-names>JE</given-names></name></person-group>. <article-title>Fluoro-less ablation: Fleeting fad or way of the future?</article-title> <source>J Cardiovasc Electrophysiol</source>. <year>2019</year> January;<volume>30</volume>(<issue>1</issue>):<fpage>89</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1111/jce.13771</pub-id><pub-id pub-id-type="pmid">30311723</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
